1887
  1. Home
  2. Eurosurveillance
  3. Volume 21, Issue 25, 23/Jun/2016
  4. Article
Meeting report Open Access
Like 0
Download

Abstract

The ECDC held an expert meeting in Stockholm on 27-28 April 2016 to discuss practical considerations for pre-exposure prophylaxis (PrEP) implementation in Europe. The meeting focused on four key areas: (i) eligibility criteria for PrEP in Europe; (ii) appropriate models of service delivery; (iii) cost-effectiveness of PrEP, and (iv) routine monitoring of people on PrEP. .

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.25.30263
2016-06-23
2024-04-18
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.25.30263
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/25/eurosurv-21-30263-4.html?itemId=/content/10.2807/1560-7917.ES.2016.21.25.30263&mimeType=html&fmt=ahah

References

  1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.  https://doi.org/10.1056/NEJMoa1011205  PMID: 21091279 
  2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.  https://doi.org/10.1056/NEJMoa1108524  PMID: 22784037 
  3. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53-60.  https://doi.org/10.1016/S0140-6736(15)00056-2  PMID: 26364263 
  4. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. ANRS IPERGAY Study Group. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015;373(23):2237-46.  https://doi.org/10.1056/NEJMoa1506273  PMID: 26624850 
  5. World Health Organization (WHO). Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: WHO; 2015.
  6. European Centre for Disease Prevention and Control (ECDC), WHO Regional Office for Europe (WHO). HIV/AIDS Surveillance in Europe 2014. Stockholm: ECDC/WHO; 2015.
  7. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe 2013. Stockholm: ECDC; 2013.
  8. European Centre for Disease Prevention and Control (ECDC). HIV and STI prevention among men who have sex with men. Stockholm: ECDC; 2015.
  9. United States Centers for Disease Control and Prevention (CDC). Pre-exposure prophylaxis for the prevention of HIV infection in the United States, 2014. Atlanta: CDC; 2014.
  10. European AIDS Clinical Society (EACS). EACS Guidelines, Version 8.0. Brussels: EACS, 2015.
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error